Mehr Klarheit bei hypersensitiver Blase
Erste deutsche S2k-Leitlinie zur interstitiellen Zystitis
Fortbildung
First Online:
- 1 Downloads
Bei der hypersensitiven Blase handelt es sich um ein schwerwiegendes Krankheitsbild, das nach wie vor viele Rätsel aufgibt. Um die Diagnostik und Behandlung dieser seltenen Erkrankung zu verbessern, wurde nun erstmalig eine deutschsprachige S2k-Leitlinie zum Thema interstitiellen Zystitis und zum Blasenschmerzsyndrom verfasst.
Literatur
- 1.S2k-Leitlinie „Diagnostik und Therapie der Interstitiellen Cystitis (IC/BPS)“ der Deutschen Gesellschaft für Urologie (www.awmf.org/leitlinien/detail/ll/043-050.html)
- 2.Davis NF et al. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014; 174: 30–7CrossRefGoogle Scholar
- 3.Oemler M et al. Psychosocial aspects of interstitial cystitis. Do biographical factors have a relevant impact on the disease course? Der Urologe, 2006; 45: 728–33CrossRefGoogle Scholar
- 4.FitzGerald M et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012; 187: 2113–8CrossRefGoogle Scholar
- 5.Berner MM et al. The german version of the female sexual function index (FSFI-d). Int J Impot Res. 2002; 14: 79–90CrossRefGoogle Scholar
- 6.Kuo YC et al. Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women. Int J Clin Pract. 2012; 66: 146–51CrossRefGoogle Scholar
- 7.Störkel S. Interstitielle Zystitis aus der Sicht der Pathologen. In: Interstitielle Zystitis — The State of the Art, Biermann Verlag, Köln, 2002: 43–8Google Scholar
- 8.Homma Y et al. Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis. J Urol. 2013; 190: 1925–31CrossRefGoogle Scholar
- 9.Kutlar A et al. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 2012; 87: 536–9CrossRefGoogle Scholar
- 10.Hanno PM et al. Conservative therapy of interstitial cystitis. Semin Urol. 1991; 9: 143–7PubMedGoogle Scholar
- 11.Jocham D et al. The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients. Urologe A. 2013; 52: 691–702CrossRefGoogle Scholar
- 12.Bouchelouche K et al. Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist. Urology. 2001; 57 (6 Suppl 1): 118CrossRefGoogle Scholar
- 13.Fleischmann J. Calcium channel antagonists in the treatment of interstitial cystitis. Urol Clin North Am. 1994; 21: 107–11PubMedGoogle Scholar
- 14.Homma Y et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol. 2009; 16: 597–615CrossRefGoogle Scholar
- 15.Hanno PM et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015; 193: 1545–53CrossRefGoogle Scholar
- 16.Riedl CR et al. Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J Endourol. 1998; 12: 269–72CrossRefGoogle Scholar
- 17.Peters KM et al. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007; 100: 835–9CrossRefGoogle Scholar
- 18.Lampel, A., Operations Optionen bei refraktärer interstitieller Zystitis. 2014, Schwarzwald-Baar Klinikum Villingen-Schwenningen.Google Scholar
- 19.Irwin PP et al. Surgical management of interstitial cystitis. Urol Clin North Am. 1994; 21: 145–51PubMedGoogle Scholar
Copyright information
© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019